161 related articles for article (PubMed ID: 8610975)
1. Oral tolerance in experimental autoimmune encephalomyelitis.
Whitacre CC; Gienapp IE; Meyer A; Cox KL; Javed N
Ann N Y Acad Sci; 1996 Feb; 778():217-27. PubMed ID: 8610975
[TBL] [Abstract][Full Text] [Related]
2. Treatment of autoimmune disease by oral tolerance to autoantigens.
Whitacre CC; Gienapp IE; Meyer A; Cox KL; Javed N
Clin Immunol Immunopathol; 1996 Sep; 80(3 Pt 2):S31-9. PubMed ID: 8811061
[TBL] [Abstract][Full Text] [Related]
3. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.
Chen Y; Inobe J; Kuchroo VK; Baron JL; Janeway CA; Weiner HL
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):388-91. PubMed ID: 8552644
[TBL] [Abstract][Full Text] [Related]
4. Oral tolerance as therapy for experimental autoimmune encephalomyelitis and multiple sclerosis: demonstration of T cell anergy.
Jewell SD; Gienapp IE; Cox KL; Whitacre CC
Immunol Cell Biol; 1998 Feb; 76(1):74-82. PubMed ID: 9553779
[TBL] [Abstract][Full Text] [Related]
5. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein.
Bitar DM; Whitacre CC
Cell Immunol; 1988 Apr; 112(2):364-70. PubMed ID: 2451570
[TBL] [Abstract][Full Text] [Related]
6. Antigen-driven peripheral immune tolerance: suppression of experimental autoimmmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen.
al-Sabbagh A; Nelson PA; Akselband Y; Sobel RA; Weiner HL
Cell Immunol; 1996 Jul; 171(1):111-9. PubMed ID: 8660845
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
[TBL] [Abstract][Full Text] [Related]
8. Exquisite peptide specificity of oral tolerance in experimental autoimmune encephalomyelitis.
Javed NH; Gienapp IE; Cox KL; Whitacre CC
J Immunol; 1995 Aug; 155(3):1599-605. PubMed ID: 7543526
[TBL] [Abstract][Full Text] [Related]
9. IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis.
Inobe J; Slavin AJ; Komagata Y; Chen Y; Liu L; Weiner HL
Eur J Immunol; 1998 Sep; 28(9):2780-90. PubMed ID: 9754565
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. III. A role for anergy/deletion.
Tan LJ; Vanderlugt CL; McRae BL; Miller SD
Autoimmunity; 1998; 27(1):13-28. PubMed ID: 9482204
[TBL] [Abstract][Full Text] [Related]
11. Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes.
Slavin AJ; Maron R; Weiner HL
Int Immunol; 2001 Jun; 13(6):825-33. PubMed ID: 11369711
[TBL] [Abstract][Full Text] [Related]
12. Reduced experimental autoimmune encephalomyelitis after intranasal and oral administration of recombinant lactobacilli expressing myelin antigens.
Maassen CB; Laman JD; van Holten-Neelen C; Hoogteijling L; Groenewegen L; Visser L; Schellekens MM; Boersma WJ; Claassen E
Vaccine; 2003 Dec; 21(32):4685-93. PubMed ID: 14585676
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats.
Li HL; Liu JQ; Bai XF; vn der Meide PH; Link H
Immunology; 1998 Jul; 94(3):431-7. PubMed ID: 9767428
[TBL] [Abstract][Full Text] [Related]
14. Oral tolerance to copolymer 1 in myelin basic protein (MBP) TCR transgenic mice: cross-reactivity with MBP-specific TCR and differential induction of anti-inflammatory cytokines.
Maron R; Slavin AJ; Hoffmann E; Komagata Y; Weiner HL
Int Immunol; 2002 Feb; 14(2):131-8. PubMed ID: 11809732
[TBL] [Abstract][Full Text] [Related]
15. Effect of oral beta interferon on subsequent immune responsiveness.
Nelson PA; Akselband Y; Dearborn SM; Al-Sabbagh A; Tian ZJ; Gonnella PA; Zamvil SS; Chen Y; Weiner HL
Ann N Y Acad Sci; 1996 Feb; 778():145-55. PubMed ID: 8610968
[TBL] [Abstract][Full Text] [Related]
16. Rapid depletion of peripheral antigen-specific T cells in TCR-transgenic mice after oral administration of myelin basic protein.
Meyer AL; Benson J; Song F; Javed N; Gienapp IE; Goverman J; Brabb TA; Hood L; Whitacre CC
J Immunol; 2001 May; 166(9):5773-81. PubMed ID: 11313421
[TBL] [Abstract][Full Text] [Related]
17. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit.
Sun JB; Rask C; Olsson T; Holmgren J; Czerkinsky C
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7196-201. PubMed ID: 8692968
[TBL] [Abstract][Full Text] [Related]
18. Orally administered myelin basic protein in neonates primes for immune responses and enhances experimental autoimmune encephalomyelitis in adult animals.
Miller A; Lider O; Abramsky O; Weiner HL
Eur J Immunol; 1994 May; 24(5):1026-32. PubMed ID: 7514126
[TBL] [Abstract][Full Text] [Related]
19. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide.
Khoury SJ; Lider O; al-Sabbagh A; Weiner HL
Cell Immunol; 1990 Dec; 131(2):302-10. PubMed ID: 1700738
[TBL] [Abstract][Full Text] [Related]
20. Tolerance and autoimmunity in TCR transgenic mice specific for myelin basic protein.
Goverman J
Immunol Rev; 1999 Jun; 169(1):147-59. PubMed ID: 10450515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
